TRIM34 modulates influenza virus-activated programmed cell death by targeting Z-DNA-binding protein 1 for K63-linked polyubiquitination
出版年份 2022 全文链接
标题
TRIM34 modulates influenza virus-activated programmed cell death by targeting Z-DNA-binding protein 1 for K63-linked polyubiquitination
作者
关键词
influenza A virus, programmed cell death, ZBP1, TRIM34, polyubiquitination
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 298, Issue 3, Pages 101611
出版商
Elsevier BV
发表日期
2022-01-20
DOI
10.1016/j.jbc.2022.101611
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis
- (2020) Ting Zhang et al. CELL
- Cytoplasm and Beyond: The Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I
- (2019) GuanQun Liu et al. JOURNAL OF VIROLOGY
- ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death
- (2017) Sannula Kesavardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulation and functions of NLRP3 inflammasome during influenza virus infection
- (2017) Teneema Kuriakose et al. MOLECULAR IMMUNOLOGY
- DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death
- (2016) Roshan J. Thapa et al. Cell Host & Microbe
- Generation of influenza A viruses as live but replication-incompetent virus vaccines
- (2016) L. Si et al. SCIENCE
- Influenza A Virus Infection, Innate Immunity, and Childhood
- (2015) Bria M. Coates et al. JAMA Pediatrics
- Cellular Inhibitor of Apoptosis Protein cIAP2 Protects against Pulmonary Tissue Necrosis during Influenza Virus Infection to Promote Host Survival
- (2014) Ian Gaël Rodrigue-Gervais et al. Cell Host & Microbe
- Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages
- (2014) S. McComb et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenic potential of interferon αβ in acute influenza infection
- (2014) Sophia Davidson et al. Nature Communications
- Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels
- (2013) Catherine J. Sanders et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection
- (2013) Marlène Brandes et al. CELL
- Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases
- (2013) R. J. Thapa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type I IFN Triggers RIG-I/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells
- (2013) Julien Pothlichet et al. PLoS Pathogens
- DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA
- (2012) Jason W. Upton et al. Cell Host & Microbe
- Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury
- (2012) Susanne Herold et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Exudate Macrophages Attenuate Lung Injury by the Release of IL-1 Receptor Antagonist in Gram-negative Pneumonia
- (2011) Susanne Herold et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins
- (2011) Taro Kawai et al. EMBO Molecular Medicine
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA
- (2009) Irving C. Allen et al. IMMUNITY
- The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1
- (2009) Paul G. Thomas et al. IMMUNITY
- TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
- (2008) Ken J. Ishii et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started